FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women

FDA Direct: кто покупает спин — крючок, леску и грузило?

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Medical Device Quality Management System Regulation Design and Development

FDA Direct: эти 9 препаратов получили национальные приоритетные ваучеры

FDA Direct: Catching Up on Agency Reforms

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

FDA Direct: To Boost or Not to Boost - Gathering New Evidence on Covid Boosters

FDA Direct: From Menopause to Food Safety: FDA's Latest Regulatory Priorities

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

FDA Expert Panel on Testosterone Replacement Therapy for Men

Medical Device Quality Management System Regulation Risk Management

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

FDA Direct: Dramatically lowering drug prices for Americans

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

FDA Direct, Ep. 1: Live from the FDA! - What We're Working On at FDA

FDA Direct: FDA Awards Six National Priority Vouchers

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S07 – Q&A Discussion Panel